CD19-BAFF CAR-T Cells

CD19-BAFF chimeric antigen receptor T cells · Zhejiang University

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD19-BAFF CAR-T Cells, covering 2024-05-14 to 2024-05-14. Get the full timeline:

Most recent: Clinical Trial Update: CD19-BAFF CAR-T Cells Therapy for Patients With Relapsed / Refractory B-cell ALL and B-cell NHL [EARLY_Phase 1]